Solmeyea Athens, Greece

Company Website: https://solmeyea.com

Company Email: info@solmeyea.com

Employees: 9

Funding State: Seed


Industries

  • AgriTech / FoodTech

Technology

  • Cleantech
  • Other

Business Model

  • B2B
  • B2B2C

Revenue Model

  • Commission Fee
  • Licencing
  • Other
  • Price per Item

Funding Sources

  • Grant
  • Self

About

Solmeyea is a purpose-driven Agri - BioTech venture producing more efficiently “carbon neutral” high value bioingredient-based proteins, through our vertical microalgae cultivation & harvesting (utilizing the freely available CO2 & sunlight), enabling the food, feed & Pharma industries manufacture high value algal based premium end products for a significant lower cost with a phenomenal lower carbon footprint, abiding by the circular economy’s morals and goals.


Solution & Product

Humanity faces a double-faced problem: overpopulation & livestock revolution creating a growing demand for food+protein, which won’t be met due to: land scarcity Earth’s heat-up (CO2 emissions) Food & Feed manufacturers avidly look for soy substitute like microalgae derived proteins, given their double protein content, high digestibility & nutritional value making food industry confident about its end products, avoiding breeding animals’ food shocks or reproduction delays due to low quality & possible contaminations (mold) Solmeyea enables its B2B food & feed industries manufacture high value algal based premium end products for a significant lower cost with a phenomenal lower carbon footprint, abiding by the circular economy’s morals and goals, taking also advantage of the ESG criteria and lowering their debt cost by cutting their existing loans’ interest rates by (5-300 basis points); thus, return the initial CAPEX within the first year due to GHG & carbon footprint reductio We are using biotech cutting-edge technologies relying on life’s oldest mechanism: photosynthesis: Solmeyea, already awarded with the Seal of Excellence, strategically located at the south-eastern Europe with the highest annual natural sunlight offers a microalga farming producing pure high-value bioproducts, such as: proteins & vitamins to the food industry at a 5x lower cost, utilizing certain CO2 emissions to further boost its microalgae process and create a positive environmental impact


Innovation & Scalability

Solmeyea USP’s being a purpose-driven Agri - BioTech startup producing in the most cost-competitive and eco-friendly way “carbon neutral” high value bioingredient-based proteins: 1) undeniably higher content & efficient way for food production, compared to traditional sources, like: Soy & Hay 2) incomparably more nutritional and digestible, full of omega 3’s, carbohydrates, polysaccharides, lipids and carotenoids 3) verified vertical microalgae cultivation methods (utilizing CO2 & sunlight) 4) end products - phenomenal lower carbon footprint


Traction & achievements

Seal of Excellence MITEF Greece accelerator National Grant EIT member of Food, Climate KIC, Energy, Health clusters 2 established pilot production lines with PPC S.A. & NSCR Demokritos 2 patents


Team & Why Us

Solmeyea’s founders have lived, studied and worked in the EU, US & Africa for 10+ years and successfully launched 3 ventures, separately. What Solmeyea does is sustainable, qualitative and efficient given microalgae’s higher food protein content & its complementary production of feed, pharma, cosmetics & biofertilizers. Moreover we will soon explore the biodegradable bioplastic packaging solutions (coming from microalgal biomass) for the innovative food applications in line with circular bioeconomy models by valorizing the exhausted algae biomass at its fullest extent and gladly contribute to the EU’s 2050 long-term strategy for a climate-neutral Europe by replacing fossil-based plastic packaging with bio-based, renewables. Vasilis Stenos – Founder - environmental & agricultural Engineer, EIT evaluator Markos Kiosseoglou - COO, fundraising - MBA finance Dr. Dimitra Karageorgou- CTO, Algae specialist, PhD microbiology Diego Grumbach – Microbiologist - Biotechnologist Georgiana Stenou - Ops manager, Physicist industrial R&D


Funding Needs

....................................................................................1.5M....................................................................................................


ONE LINER

highly functional plant-based protein isolates & biomolecules through vertical microalgae farming


TEAM


FUNDING

2022 - Pre Seed, Loan / Investment Bank EUR 400K, HDB

PATENTS

European Patent Office - Pending EPO
US Patent & Trademark Office - Pending USPTO

AWARDS

2022 - Services MassChallenge Israel
2021 - Funding EIT FAN
2020 - Funding EIT Climate KIC
2020 - Funding The Hellenic Initiative
2019 - Services GreenTech Challenge
2019 - Funding JA Greece
2019 - Services Seal of Excellence
2019 - Services JA Europe
2019 - Services Start-ups Ignite Washington DC

INCUBATIONS/ACCELERATIONS

2022 - Program MassChallenge Israel (alternative proteins)
2021 - Program EIT Food Accelerated Network South CLC (Bilbao & Madrid)
2021 - Program EIT Hub Israel \"Calling2Scale\"
2020 - Program EIT Climate KIC Accelerator Greece
2019 - Program MIT Entreprise Forum

Jobs


Perks